Determinations of Levels of Human Immunodeficiency Virus Type 1 RNA in Plasma: Reassessment of Parameters Affecting Assay Outcome
Judy Lew(National Institute of Allergy and Infectious Diseases), Torange Yeghiazarian(Novartis (Switzerland)), Michael Cronin(University College Cork), Marsha D. Fowler(National Institute of Allergy and Infectious Diseases), Kenneth McIntosh(Boston University), Thomas C. Quinn(Johns Hopkins University), William A. Meyer(Quest Diagnostics (United States)), Robin E. Carrol(Eon Corporation (United States)), P S Reichelderfer(National Institute of Allergy and Infectious Diseases), Steven A. Herman(Roche (Switzerland)), Barbara Weiser(New York State Department of Health), Robert W. Coombs(University of Namur), Jack Moye(National Institutes of Health), N. Michael(Walter Reed Army Institute of Research), Ruth Dickover(University of California, Davis), Merlin L. Robb(University of Maryland, Baltimore), Maryanne Vahey(Walter Reed Army Institute of Research), Lynne Mofenson(Elizabeth Glaser Pediatric AIDS Foundation), J. Kornegay, James W. Bremer(Rush University Medical Center), Andrea Kovács(University of Southern California), Susan A. Fiscus(University of North Carolina at Chapel Hill), J. Brooks Jackson(VA Tennessee Valley Healthcare System), S Cassol(Ottawa Hospital), David Chernoff(Alta Bates Summit Medical Center)
Cited by 86
Related Papers
Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine Treatment
|New England Journal of Medicine|1994|3.7k
Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women
|New England Journal of Medicine|2012|3.3k
Identification of a Reservoir for HIV-1 in Patients on Highly Active Antiretroviral Therapy
|Science|1997|3.1k
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
|New England Journal of Medicine|2021|2.6k